Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Otogenetics Hearing Loss and Deafness Multi-Gene NGS Panel Otogenetics United States | 123 | 129 |
|
Centogene US, LLC - The Rare Disease Company United States | 316 | 314 |
|
Centogene US, LLC - The Rare Disease Company United States | 203 | 194 |
|
Centogene US, LLC - The Rare Disease Company United States | 829 | 848 |
|
KCNJ10 - NGS including CNV analysis Centogene US, LLC - The Rare Disease Company United States | 2 | 1 |
|
SLC26A4 - NGS including CNV analysis Centogene US, LLC - The Rare Disease Company United States | 2 | 1 |
|
FOXI1 - NGS including CNV analysis Centogene US, LLC - The Rare Disease Company United States | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 316 | 314 |
|
FOXI1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
SLC26A4 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
KCNJ10 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Carrier Screening Guidelines-Based Panel Ambry Genetics United States | 199 | 165 |
|
Centogene AG - the Rare Disease Company Germany | 203 | 194 |
|
Centogene AG - the Rare Disease Company Germany | 829 | 848 |
|
Invitae Leukodystrophy and Genetic Leukoencephalopathy Panel Invitae United States | 971 | 680 |
|
Invitae Renal Tubular Disorders Panel Invitae United States | 68 | 39 |
|
Invitae Comprehensive Neurometabolic Disorders Panel Invitae United States | 351 | 249 |
|
Invitae Comprehensive Deafness Panel Invitae United States | 405 | 219 |
|
Molecular Otolaryngology and Renal Research Laboratories University of Iowa Hospital and Clinics United States | 288 | 218 |
|
Invitae United States | 66 | 40 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.